ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Inventiva

Inventiva (6IV)

3,225
0,00
( 0,00% )
Mis à jour : 10:04:38

Inventiva (6IV) Répartition de la Propriété

Institutions
56.80%
Initiés
4.48%
Public et Autres
38.72%

Inventiva (6IV) Propriété

Actionnaire Type Détenues (Réel) % en Circulation Valeur Marchande Date de Reporte
JPMorgan Chase & Co.Institution21 028 37310,12%67,82M €2026-05-18
Invus Public Equities, L.P.Institution15 945 0677,68%51,42M €2025-11-13
Artal Group S.A.Institution15 945 0677,68%51,42M €2025-11-13
Andera PartnersInstitution14 114 4766,80%45,52M €2026-03-31
Samsara BioCapital LLCInstitution13 540 1946,52%43,67M €2026-03-31
Sofinnova Crossover IInstitution12 332 8045,94%39,77M €2025-12-31
Eventide Healthcare Innovation Fund I LPInstitution9 368 5174,51%30,21M €2025-12-31
Eventide Asset Management, LLCInstitution9 368 5174,51%30,21M €2026-03-31
BVF Partners L.P.Institution8 545 4994,11%27,56M €2026-03-31
Sofinnova Partners SASInstitution8 433 2274,06%27,20M €2026-06-02
Samsara Biocapital, L.P.Institution8 345 3894,02%26,91M €2025-11-17
Deep Track Biotechnology Master Fund, LtdInstitution7 800 4653,76%25,16M €2026-03-31
Deep Track Capital, LPInstitution7 800 4653,76%25,16M €2026-03-31
Perceptive Advisors LLCInstitution6 945 9953,34%22,40M €2025-09-30
Perceptive Life Sciences Master Fund, Ltd.Institution6 945 9953,34%22,40M €2025-09-30
New Enterprise Associates, Inc.Institution6 684 0643,22%21,56M €2026-03-31
New Enterprise Associates 17, L.P.Institution6 684 0643,22%21,56M €2026-03-30
Mr. Frederic CrenInitiés5 878 9912,83%18,96M €2026-03-04
Qatar Holding LLCInstitution5 157 2332,48%16,63M €2025-07-22
Caligan Partners, LPInstitution4 974 9062,40%16,04M €2026-03-31
Polar Capital Holdings PlcInstitution4 632 1382,23%14,94M €2026-03-31
Biotechnology Value Fund L.P.Institution4 630 4612,23%14,93M €2025-11-17
Paradigm Biocapital Advisors LPInstitution4 000 0001,93%12,90M €2026-03-31
Biomedical Value FundInstitution3 658 9441,76%11,80M €2025-09-30
Great Point Partners, LLCInstitution3 449 9371,66%11,13M €2025-12-31
Biotechnology Value Fund II, L.P.Institution3 321 8611,60%10,71M €2025-11-17
Millennium Management LLCInstitution2 987 6131,44%9,64M €2026-03-31
Trails Edge Capital Partners, LPInstitution2 657 9971,28%8,57M €2026-03-31
Franklin Resources, Inc.Institution2 461 5651,19%7,94M €2026-03-31
Symbiosis Capital Partners, LLCInstitution2 354 0001,13%7,59M €2026-03-31
UBS Asset Management AGInstitution2 318 6931,12%7,48M €2026-03-31
Ally Bridge GroupInstitution2 245 3001,08%7,24M €2026-03-31
ADAR1 Capital Management, LLCInstitution2 174 3981,05%7,01M €2026-03-31
The Goldman Sachs Group, Inc.Institution1 932 1600,93%6,23M €2026-03-31
NEA 18 Venture Growth Equity, L.P.Institution1 666 6660,80%5,37M €2026-03-30
Biomedical Offshore Value Fund, LTD.Institution1 643 8740,79%5,30M €2025-09-30
Boothbay Fund Management, LLCInstitution1 470 4070,71%4,74M €2026-03-31
Ikarian Capital, LLCInstitution1 429 1010,69%4,61M €2026-03-31
Nextbio Capital Management LpInstitution1 333 4840,64%4,30M €2026-03-31
RTW Investments, LPInstitution1 298 7020,63%4,19M €2026-03-31
Artisan Partners Limited PartnershipInstitution960 8650,46%3,10M €2026-03-31
Point72 Asset Management, L.P.Institution956 2210,46%3,08M €2026-03-31
Columbia Management Investment Advisers, LLCInstitution844 2150,41%2,72M €2026-03-31
FMR LLCInstitution719 7540,35%2,32M €2026-04-30
Marshall Wace LLPInstitution654 2110,31%2,11M €2026-03-31

Dernières Valeurs Consultées

Delayed Upgrade Clock